Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2020 pubmed 6 citations

Hypothalamic and brain stem neurochemical profile in anorectic rats after peripheral administration of kisspeptin-10 using <sup>1</sup> H-nmr spectroscopy in vivo.

Skowron. Kamil K; Jasi&#x144;ski. Krzysztof K; Kurnik-&#x141;ucka. Magdalena M; Stach. Paulina P; Kalita. Katarzyna K; W&#x119;glarz. W&#x142;adys&#x142;aw P WP; Gil. Krzysztof K

Key Findings

  • Kisspeptin-10 increased food intake and altered weight‑loss patterns in anorexic rats.
  • Brain metabolite levels shifted: creatine dropped, phosphocreatine rose, GABA fell, glutathione and inositol went up.
  • Kisspeptin reversed the drop in hypothalamic GABA and creatine and restored brain‑stem glutamate levels.

Practical Outcomes

  • The results hint that kisspeptin could be explored as an appetite‑stimulating agent, especially for conditions linked to low food intake. However, because the work is limited to rodents and the dosing is unclear, it’s not ready for self‑experimentation or clinical use. Biohackers should wait for human trials before considering kisspeptin for metabolic or weight‑management protocols.

Summary

In a rat model of anorexia, giving the peptide kisspeptin-10 under the skin helped the animals eat more and changed several brain chemicals linked to energy use. The study shows kisspeptin can affect appetite by tweaking signals in the hypothalamus, but it’s only been tested in mice, not people.

Abstract

Although anorexia nervosa is classified as a psychiatric disorder associated with socio-environmental and psychological factors, a deeper insight into the dominant neurobiological basis is needed to develop a more effective approach of treatment. Given the high contribution of genetic predisposition and the underlying pathophysiology of neurohormonal circuits, it seems that pharmacological targeting of these mechanisms may provide us with better therapeutic outcomes. <sup>1</sup> H-NMR spectroscopy was used to measure concentrations of the hypothalamus and brain stem metabolites in an activity-based rodent model (ABA) after subcutaneous administration of kisspeptin-10. Because anorexia mainly affects young women and often leads to hypogonadotropic-hypogonadism, we investigated the influence of this neuropeptide, which is involved in reproductive function by regulating the hypothalamic-pituitary-gonadal axis, on the ABA model development. Kisspeptin reinforced food consumption in an activity-based rodent model of anorexia changing a pattern of weight loss. <sup>1</sup> H-NMR spectroscopy of the hypothalamus and brain stem of ABA rats revealed a statistically significant change in the concentration of creatine (Cr; decreased, P = 0.030), phosphocreatine (PCr; increased, P = 0.030), &#x3b3;-aminobutyric acid (GABA; decreased, P = 0.011), glutathione (GSH; increased, P = 0.011) and inositol (INS; increased, P = 0.047) compared to the control group. Subcutaneous administration of kisspeptin reversed the decrease in GABA (P = 0.018) and Cr (P = 0.030) levels in the hypothalamus as well as restored glutamate (GLU; P = 0.040) level in the brain stem. We suspect that kisspeptin through modulation of hypothalamic GABAergic signaling increases food intake, and thus positively alters brain metabolism.

Study Information

Provider

pubmed

Year

2020

Date

2020-04-06T00:00:00.000Z

DOI

10.1002/nbm.4306

Citations

6

References

50